Home Irish company develops 'MedBot' for COVID-19 self-testing at home

Irish company develops 'MedBot' for COVID-19 self-testing at home

Press Release: March 20, 2020

Leading Dublin Digital Health Startup Akkure launches ‘COVIDMedBot’- a virtual service providing personalised risk assessment and guidelines during the COVID-19 pandemic for patients, hospitals and GPs. Free to use, the COVID MedBot provides personalised risk assessment and guidelines, in line with the HSE recommendations and leveraging advice from the WHO and CDC, regarding the COVID-19 virus. The tool is available online at https://www.akkure4covid.com , and the assessment can be completed in just 90 seconds. The public can turn to the COVIDMedBot for the latest individualised advice on the evolving COVID-19 pandemic, enabling quick risk assessment in an uncertain environment. The COVIDMedBot is dynamically updated based on an individual’s specific responses. The risk assessment can be repeated as many times as a user wants, facilitating sequential consults, critical in the rapidly evolving clinical situation. Complementary to this free service:
  • Akkure is releasing specialised MedBots; available to leading hospitals and
medical practices, tailored to their individual needs to assist with triaging patients and relieve the immense pressure on their organisations during the COVID-19 pandemic. The founder of Akkure, Prof. Oran Rigby MD said, “Our COVIDMedBot offers an efficient and reliable service benefiting the public, corporate sector, and Irish governing bodies during this high strain period for the health service. The COVIDMedBot’s data is based on the latest scientifically validated information from the HSE, the CDC and the WHO, along with doctors and medical experts at St. Vincent’s University Hospital, a frontline healthcare institution in addressing the anticipated COVID-19 outbreak. We are confident the service will put users in a better position to handle the current situation whilst alleviating the HSE of a significant amount of pressure.”

Notes to editors

For more information, please contact:

Lily M

Email: lily.m@akkure.com

Visit the newsroom of: sampr